Building charisma and trust with prosodic constructions
Pragmatics and Society · 29.10.2026 · 17 (5) · 555-575
DOI: 10.1075/ps.25052.nie ↗Kurz gefasst
Fachartikel in der Zeitschrift Pragmatics and Society, online erschienen am 15.10.2026. Verfasst von Oliver Niebuhr und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
The present paper uses a perception experiment to investigate which prosodic factors determine the perceived charisma and trustworthiness conveyed by phrase-final intonation contours. The following factors were manipulated using PSOLA resynthesis and combined into 16 stimuli: phrase-final pitch level (low vs. half-low), shape of fall (accelerated vs. decelerated), nuclear pitch-accent timing (H+L* vs. L+H*), and final lengthening (present vs. absent). Authentic statements by two U.S. politicians, a man and a woman, served as base stimuli. Forty native speakers of American-English rated the stimuli. Results showed that all factors influenced the listeners. The highest ratings were achieved by low and steep final falls, early H+L* pitch accent, and without final lengthening. Moreover, the rating levels for the female stimuli were generally higher but declined more under unfavorable phrase-final patterns. The results are in line with previous studies and are discussed with regard to practical implications and the notion of prosodic constructions.
Zitieren
APA
Niebuhr, O., & Silber-Varod, V. (2026). Building charisma and trust with prosodic constructions. Pragmatics and Society, 17(5), 555-575. https://doi.org/10.1075/ps.25052.nie
Vancouver
Niebuhr O, Silber-Varod V. Building charisma and trust with prosodic constructions. Pragmatics and Society. 2026;17(5):555-575. doi:10.1075/ps.25052.nie
BibTeX
@article{Niebuhr2026,
author = {Niebuhr, Oliver and Silber-Varod, Vered},
title = {Building charisma and trust with prosodic constructions},
journal = {Pragmatics and Society},
year = {2026},
volume = {17},
number = {5},
pages = {555--575},
doi = {10.1075/ps.25052.nie}
}
EUVIMED